Outset Medical Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Outset Medical stock has a consensus rating of "Buy" and an average price target of $8.33. The average 1-year stock price forecast is 93.27% higher than the current stock price, while the lowest is $7.00 (+62.41%) and the highest is $10 (+132.02%).

Price Target: $8.33 (+93.27%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$8.33	$8.00	$10
Change	+62.41%	+93.27%	+85.61%	+132.02%

* Price targets were last updated on May 8, 2026.

Analyst Ratings

The average analyst rating for Outset Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Josh Jennings TD Cowen	TD Cowen	Buy Reiterates $12 → $10	Buy	Reiterates	$12 → $10	+132.02%	May 8, 2026
Rick Wise Stifel Nicolaus	Stifel Nicolaus	Buy Reiterates $8 → $6	Buy	Reiterates	$8 → $6	+39.21%	May 8, 2026
Shagun Singh Chadha RBC Capital	RBC Capital	Hold Reiterates $7	Hold	Reiterates	$7	+62.41%	May 8, 2026
Marie Thibault BTIG	BTIG	Buy Maintains $15	Buy	Maintains	$15	+248.03%	Feb 18, 2026

Financial Forecast

Revenue This Year

126.60M

from 119.48M

5.96%

from 119.48M

Revenue Next Year

140.37M

from 126.60M

10.87%

from 126.60M

EPS This Year

-2.89

from -4.30

EPS Next Year

-2.18

from -2.89

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	102.60M	115.38M	130.38M	113.69M	119.48M	126.60M
Revenue Growth	105.47%	12.45%	13.00%	-12.80%	5.09%	5.96%
Gross Profit	7.61M	17.83M	29.13M	39.14M	46.75M	55.66M
Gross Margin	7.42%	15.46%	22.34%	34.43%	39.13%	43.97%
Operating Income	-130.52M	-161.02M	-167.24M	-107.82M	-66.71M	-45.90M
Net Income	-131.94M	-162.96M	-172.80M	-127.98M	-81.65M	-72.00M
EPS	-	-	-	-	-4.30	-2.89
Free Cash Flow	-87.69M	-94.56M	-70.09M	-69.93M	-21.35M	41.00M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	127.5M
Avg	126.6M
Low	125.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	6.7%
Avg	6.0%
Low	4.6%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-2.89
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-